<drug type="biotech" created="2005-06-13" updated="2021-01-01">
  <drugbank-id primary="true">DB00016</drugbank-id>
  <drugbank-id>BTD00103</drugbank-id>
  <drugbank-id>BIOD00103</drugbank-id>
  <drugbank-id>DB08923</drugbank-id>
  <name>Erythropoietin</name>
  <description>Erythropoietin (EPO) is a growth factor produced in the kidneys that stimulates the production of red blood cells. It works by promoting the division and differentiation of committed erythroid progenitors in the bone marrow [FDA Label]. Epoetin alfa (Epoge) was developed by Amgen Inc. in 1983 as the first rhEPO commercialized in the United States, followed by other alfa and beta formulations. Epoetin alfa is a 165-amino acid erythropoiesis-stimulating glycoprotein produced in cell culture using recombinant DNA technology and is used for the treatment of patients with anemia associated with various clinical conditions, such as chronic renal failure, antiviral drug therapy, chemotherapy, or a high risk for perioperative blood loss from surgical procedures [FDA Label]. It has a molecular weight of approximately 30,400 daltons and is produced by mammalian cells into which the human erythropoietin gene has been introduced. The product contains the identical amino acid sequence of isolated natural erythropoietin and has the same biological activity as the endogenous erythropoietin. Epoetin alfa biosimilar, such as Retacrit (epoetin alfa-epbx or epoetin zeta), has been formulated to allow more access to treatment options for patients in the market [L2784]. The biosimilar is approved by the FDA and EMA as a safe, effective and affordable biological product and displays equivalent clinical efficacy, potency, and purity to the reference product [A7504]. Epoetin alfa formulations can be administered intravenously or subcutaneously.</description>
  <cas-number>11096-26-7</cas-number>
  <unii>64FS3BFH5W</unii>
  <state>liquid</state>
  <groups>
    <group>approved</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A7504</ref-id>
        <pubmed-id>20886265</pubmed-id>
        <citation>Brinks V, Hawe A, Basmeleh AH, Joachin-Rodriguez L, Haselberg R, Somsen GW, Jiskoot W, Schellekens H: Quality of original and biosimilar epoetin products. Pharm Res. 2011 Feb;28(2):386-93. doi: 10.1007/s11095-010-0288-2. Epub 2010 Oct 1.</citation>
      </article>
      <article>
        <ref-id>A33076</ref-id>
        <pubmed-id>1752115</pubmed-id>
        <citation>Halstenson CE, Macres M, Katz SA, Schnieders JR, Watanabe M, Sobota JT, Abraham PA: Comparative pharmacokinetics and pharmacodynamics of epoetin alfa and epoetin beta. Clin Pharmacol Ther. 1991 Dec;50(6):702-12.</citation>
      </article>
      <article>
        <ref-id>A33079</ref-id>
        <pubmed-id>14671225</pubmed-id>
        <citation>Weiss MJ: New insights into erythropoietin and epoetin alfa: mechanisms of action, target tissues, and clinical applications. Oncologist. 2003;8 Suppl 3:18-29.</citation>
      </article>
      <article>
        <ref-id>A33080</ref-id>
        <pubmed-id>18922615</pubmed-id>
        <citation>Elliott S, Pham E, Macdougall IC: Erythropoietins: a common mechanism of action. Exp Hematol. 2008 Dec;36(12):1573-84. doi: 10.1016/j.exphem.2008.08.003. Epub 2008 Oct 14.</citation>
      </article>
    </articles>
    <textbooks/>
    <links>
      <link>
        <ref-id>L2784</ref-id>
        <title>FDA News Release: FDA approves first epoetin alfa biosimilar for the treatment of anemia</title>
        <url>https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm607703.htm</url>
      </link>
    </links>
    <attachments>
      <attachment>
        <ref-id>F85</ref-id>
        <title>EMA Summary of Product Characteristics: RETACRIT (epoetin alfa-epox) injection, for intravenous or subcutaneous use</title>
        <url>//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/085/original/WC500054377.pdf?1526579130</url>
      </attachment>
      <attachment>
        <ref-id>F86</ref-id>
        <title>Epoetin Alfa (Epogen®) Product Monograph</title>
        <url>//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/086/original/EpoetinAlfaMonograph.doc?1526580354</url>
      </attachment>
    </attachments>
  </general-references>
  <synthesis-reference/>
  <indication>Indicated in adult and paediatric patients for the: &#13;
&#13;
- treatment of anemia due to Chronic Kidney Disease (CKD) in patients on dialysis and not on dialysis.&#13;
- treatment of anemia due to zidovudine in patients with HIV-infection. &#13;
- treatment of anemia due to the effects of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy.&#13;
- reduction of allogeneic RBC transfusions in patients undergoing elective, noncardiac, nonvascular surgery.</indication>
  <pharmacodynamics>Erythropoietin and epoetin alfa are involved in the regulation of erythrocyte differentiation and the maintenance of a physiological level of circulating erythrocyte mass. It is reported to increase the reticulocyte count within 10 days of initiation, followed by increases in the RBC count, hemoglobin, and hematocrit, usually within 2 to 6 weeks [F85]. Depending on the dose administered, the rate of hemoglobin increase may vary. In patients receiving hemodialysis, a greater biologic response is not observed at doses exceeding 300 Units/kg 3 times weekly [F85]. &#13;
&#13;
Epoetin alfa serves to restore erythropoietin deficiency in pathological and other clinical conditions where normal production of erythropoietin is impaired or compromised. In anemic patients with chronic renal failure (CRF), administration with epoetin alfa stimulated erythropoiesis by increasing the reticulocyte count within 10 days, followed by increases in the red cell count, hemoglobin, and hematocrit, usually within 2 to 6 weeks [FDA Label]. Epoetin alfa was shown to be effective in increasing hematocrit in zidovudine-treated HIV-infected patients and anemic cancer patients undergoing chemotherapy [FDA Label]. </pharmacodynamics>
  <mechanism-of-action>Erythropoietin or exogenous epoetin alfa binds to the erythropoietin receptor (EPO-R) and activates intracellular signal transduction pathways [A33079]. The affinity (Kd) of EPO for its receptor on human cells is ∼100 to 200 pM [A33080]. Upon binding to EPO-R on the surface of erythroid progenitor cells, a conformational change is induced which brings EPO-R-associated Janus family tyrosine protein kinase 2 (JAK2) molecules into close proximity. JAK2 molecules are subsequently activated via phosphorylation, then phosphorylate tyrosine residues in the cytoplasmic domain of the EPO-R that serve as docking sites for Src homology 2-domain-containing intracellular signaling proteins [A33079]. The signalling proteins include STAT5 that once phosphorylated by JAK2, dissociates from the EPO-R, dimerizes, and translocates to the nucleus where they serve as transcription factors to activate target genes involved in cell division or differentiation, including the apoptosis inhibitor Bcl-x [A33079]. The inhibition of apoptosis by the EPO-activated JAK2/STAT5/Bcl-x pathway is critical in erythroid differentiation. Via JAK2-mediated tyrosine phosphorylation, erythropoietin and epoetin alfa also activates other intracellular proteins involved in erythroid cell proliferation and survival, such as Shc , phosphatidylinositol 3-kinase (PI3K), and phospholipase C-γ1 [A33079]. </mechanism-of-action>
  <toxicity>Overdose from epoetin alfa include signs and symptoms associated with an excessive and/or rapid increase in hemoglobin concentration, including cardiovascular events. Patients with suspected or known overdose should be monitored closely for cardiovascular events and hematologic abnormalities. Polycythemia should be managed acutely with phlebotomy, as clinically indicated. Following resolution of the overdose, reintroduction of epoetin alfa therapy should be accompanied by close monitoring for evidence of rapid increases in hemoglobin concentration (&gt;1 gm/dL per 14 days). In patients with an excessive hematopoietic response, reduce the dose in accordance with the recommendations described in the drug label [FDA Label]. </toxicity>
  <metabolism>Binding of erythropoietin and epoetin alfa to EPO-R leads to cellular internalization, which involves the degradation of the ligand. Erythropoietin and epoetin alfa may also be degraded by the reticuloendothelial scavenging pathway or lymphatic system [A33080].</metabolism>
  <absorption>The time to reach peak concentration is slower via the subcutaneous route than the intravenous route which ranges from 20 to 25 hours, and the peak is always well below the peak achieved using the intravenous route (5–10% of those seen with IV administration) [A33080, L85]. The bioavailability of subcutaneous injectable erythropoietin is much lower than that of the intravenously administered product and is approximately 20-40% [A33080, L85]. &#13;
&#13;
**Adult and paediatric patients with CRF:** Following subcutaneous administration, the peak plasma levels are achieved within 5 to 24 hours [FDA Label]. &#13;
&#13;
**Cancer patients receiving cyclic chemotherapy:** The average time to reach peak plasma concentration was approximately 13.3 ± 12.4 hours after 150 Units/kg three times per week (TIW) subcutaneous (SC) dosing. The Cmax is expected be 3- to 7- fold higher and the Tmax is expected to be 2- to 3-fold longer in patients receiving a 40,000 Units SC weekly dosing regimen [FDA Label]. </absorption>
  <half-life>**Healthy volunteers:** The half life is approximately 4 hours in healthy volunteers receiving an intravenous injection [F85]. A half-life of approximately 6 hours has been reported in children [F85].&#13;
&#13;
**Adult and paediatric patients with CRF:** The elimination half life following intravenous administration ranges from 4 to 13 hours, which is about 20% longer in CRF patients than that in healthy subjects. The half life is reported to be similar between adult patients receiving or not receiving dialysis [FDA Label]. &#13;
&#13;
**Cancer patients receiving cyclic chemotherapy:** Following subcutaneous administration, the average half life is 40 hours with range of 16 to 67 hours [FDA Label]. </half-life>
  <protein-binding>No information of serum protein binding available. </protein-binding>
  <route-of-elimination>Erythropoietin and epoetin alfa are cleared via uptake and degradation via the EPO-R-expressing cells, and may also involve other cellular pathways in the interstitium, probably via cells in the reticuloendothelial scavenging pathway or lymphatic system [A33080]. Only a small amount of unchanged epoetin alfa is found in the urine [F86]. </route-of-elimination>
  <volume-of-distribution>In healthy volunteers, the volume of distribution of intravenous epoetin alfa was generally similar to the plasma volume (range of 40–63.80 mL/kg), indicating limited extravascular distribution [A33080, A33076]. </volume-of-distribution>
  <clearance>**Healthy volunteers: ** In male volunteers receiving intravenous epoetin alfa, the total body clearance was approximately 8.12 ± 1.00 mL/h/kg [A33076]. &#13;
&#13;
**Cancer patients receiving cyclic chemotherapy:** The average clearance was approximately 20.2 ± 15.9 mL/h/kg after 150 Units/kg three times per week (TIW) subcutaneous (SC) dosing [FDA Label]. The patients receiving a 40,000 Units SC weekly dosing regimen display a lower clearance (9.2 ± 4.7 mL/h/kg) [FDA Label]. </clearance>
  <classification>
    <description/>
    <direct-parent>Peptides</direct-parent>
    <kingdom>Organic Compounds</kingdom>
    <superclass>Organic Acids</superclass>
    <class>Carboxylic Acids and Derivatives</class>
    <subclass>Amino Acids, Peptides, and Analogues</subclass>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">E.P.O.</synonym>
    <synonym language="english" coder="">Epoetin alfa</synonym>
    <synonym language="english" coder="">Epoetin alfa rDNA</synonym>
    <synonym language="english" coder="">Epoetin alfa-epbx</synonym>
    <synonym language="english" coder="">Epoetin alfa, recombinant</synonym>
    <synonym language="english" coder="">Epoetin beta</synonym>
    <synonym language="english" coder="">Epoetin beta rDNA</synonym>
    <synonym language="english" coder="">Epoetin epsilon</synonym>
    <synonym language="english" coder="">Epoetin gamma</synonym>
    <synonym language="english" coder="">Epoetin gamma rDNA</synonym>
    <synonym language="english" coder="">Epoetin kappa</synonym>
    <synonym language="english" coder="">Epoetin omega</synonym>
    <synonym language="english" coder="">Epoetin theta</synonym>
    <synonym language="english/german" coder="">Epoetin zeta</synonym>
    <synonym language="spanish" coder="">Epoetina alfa</synonym>
    <synonym language="spanish" coder="">Epoetina beta</synonym>
    <synonym language="spanish" coder="">Epoetina dseta</synonym>
    <synonym language="spanish" coder="">Epoetina zeta</synonym>
    <synonym language="french" coder="">Epoétine zêta</synonym>
    <synonym language="latin" coder="">Epoetinum zeta</synonym>
    <synonym language="english" coder="">Erythropoiesis stimulating factor</synonym>
    <synonym language="english" coder="">Erythropoietin (human, recombinant)</synonym>
    <synonym language="english" coder="">Erythropoietin (recombinant human)</synonym>
    <synonym language="english" coder="">ESF</synonym>
    <synonym language="english" coder="">SH-polypeptide-72</synonym>
  </synonyms>
  <products>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/001</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>1000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/002</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>1000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/003</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>2000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/004</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>2000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/005</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>3000 IU/0.3ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/006</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>3000 IU/0.3ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/007</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>4000 IU/0.4ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/008</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>4000 IU/0.4ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/009</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>5000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/010</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>5000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/011</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>6000 IU/0.6ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/012</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>6000 IU/0.6ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/013</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>8000 IU/0.8ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/014</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>8000 IU/0.8ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/015</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/016</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/017</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>7000 IU/0.7ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/018</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>7000 IU/0.7ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/019</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>9000 IU/0.9ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/020</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>9000 IU/0.9ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/021</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/022</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/023</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/0.75ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/024</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/0.75ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/025</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>40000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/026</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>40000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/027</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>1000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/028</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>1000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/029</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>2000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/030</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>2000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/031</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>3000 IU/0.3ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/032</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>3000 IU/0.3ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/033</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>4000 IU/0.4ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/034</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>4000 IU/0.4ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/035</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>5000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/036</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>5000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/037</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>6000 IU/0.6ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/038</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>6000 IU/0.6ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/039</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>7000 IU/0.7ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/040</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>7000 IU/0.7ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/041</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>8000 IU/0.8ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/042</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>8000 IU/0.8ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/043</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>9000 IU/0.9ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/044</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>9000 IU/0.9ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/045</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/046</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/047</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/048</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/049</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/0.75ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/050</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/0.75ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/051</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>40000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/052</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>40000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/053</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/054</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/0.75ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Abseamed</name>
      <labeller>Medice Arzneimittel Pütter Gmb H &amp; Co. Kg</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000727</ema-product-code>
      <ema-ma-number>EU/1/07/412/055</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>40000 IU/1ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/001</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>1000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/002</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>1000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/003</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>2000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/004</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>2000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/005</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>3000 IU/0.3ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/006</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>3000 IU/0.3ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/007</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>4000 IU/0.4ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/008</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>4000 IU/0.4ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/009</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>5000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/010</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>5000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/011</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>6000 IU/0.6ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/012</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>6000 IU/0.6ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/013</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>8000 IU/0.8ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/014</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>8000 IU/0.8ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/015</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/016</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/017</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>7000 IU/0.7ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/018</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>7000 IU/0.7ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/019</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>9000 IU/0.9ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/020</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>9000 IU/0.9ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/021</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/022</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/023</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/0.75ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/024</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/0.75ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/025</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>40000 IU/1ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/026</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>40000 IU/1ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/027</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>1000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/028</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>1000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/029</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>2000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/030</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>2000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/031</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>3000 IU/0.3ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/032</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>3000 IU/0.3ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/033</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>4000 IU/0.4ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/034</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>4000 IU/0.4ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/035</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>5000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/036</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>5000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/037</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>6000 IU/0.6ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/038</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>6000 IU/0.6ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/039</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>7000 IU/0.7ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/040</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>7000 IU/0.7ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/041</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>8000 IU/0.8ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/042</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>8000 IU/0.8ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/043</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>9000 IU/0.9ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/044</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>9000 IU/0.9ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/045</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/046</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/047</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/048</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/049</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/0.75ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/050</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/0.75ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/051</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>40000 IU/1ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/052</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>40000 IU/1ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/053</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/054</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/0.75ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Binocrit</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000725</ema-product-code>
      <ema-ma-number>EU/1/07/410/055</ema-ma-number>
      <started-marketing-on>2007-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>40000 IU/1ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/001</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>1000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/002</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>1000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/003</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>2000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/004</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>2000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/005</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>3000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/006</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>3000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/007</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>4000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/008</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>4000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/009</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>5000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/010</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>5000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/011</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/012</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/013</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/014</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/015</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/016</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/017</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/018</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/019</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/020</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/021</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/022</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/023</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/024</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/025</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/026</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/027</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/028</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/029</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>1000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/030</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>2000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/031</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>3000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/032</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>4000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/033</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>5000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/034</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/035</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/036</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/037</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/038</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/039</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/040</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/041</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Biopoin</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001036</ema-product-code>
      <ema-ma-number>EU/1/09/565/042</ema-ma-number>
      <started-marketing-on>2009-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/001</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>1000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/002</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>1000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/003</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>2000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/004</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>2000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/005</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>3000 IU/0.3ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/006</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>3000 IU/0.3ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/007</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>4000 IU/0.4ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/008</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>4000 IU/0.4ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/009</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>5000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/010</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>5000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/011</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>6000 IU/0.6ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/012</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>6000 IU/0.6ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/013</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>8000 IU/0.8ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/014</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>8000 IU/0.8ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/017</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>7000 IU/0.7ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/018</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>7000 IU/0.7ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/019</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>9000 IU/0.9ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/020</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>9000 IU/0.9ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/023</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/0.75ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/024</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/0.75ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/027</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>1000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/028</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>1000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/029</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>2000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/030</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>2000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/031</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>3000 IU/0.3ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/032</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>3000 IU/0.3ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/033</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>4000 IU/0.4ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/034</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>4000 IU/0.4ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/035</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>5000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/036</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>5000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/037</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>6000 IU/0.6ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/038</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>6000 IU/0.6ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/039</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>7000 IU/0.7ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/040</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>7000 IU/0.7ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/041</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>8000 IU/0.8ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/042</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>8000 IU/0.8ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/043</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>9000 IU/0.9ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/044</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>9000 IU/0.9ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/049</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/0.75ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/050</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/0.75ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/054</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/0.75ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/055</ema-ma-number>
      <started-marketing-on>2007-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>40000 IU/1ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/015</ema-ma-number>
      <started-marketing-on>2007-08-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/016</ema-ma-number>
      <started-marketing-on>2007-08-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/021</ema-ma-number>
      <started-marketing-on>2007-08-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/022</ema-ma-number>
      <started-marketing-on>2007-08-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/025</ema-ma-number>
      <started-marketing-on>2007-08-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/026</ema-ma-number>
      <started-marketing-on>2007-08-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/045</ema-ma-number>
      <started-marketing-on>2007-08-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/046</ema-ma-number>
      <started-marketing-on>2007-08-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/047</ema-ma-number>
      <started-marketing-on>2007-08-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/048</ema-ma-number>
      <started-marketing-on>2007-08-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/051</ema-ma-number>
      <started-marketing-on>2007-08-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/052</ema-ma-number>
      <started-marketing-on>2007-08-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epoetin Alfa Hexal</name>
      <labeller>Hexal Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000726</ema-product-code>
      <ema-ma-number>EU/1/07/411/053</ema-ma-number>
      <started-marketing-on>2007-08-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Epogen</name>
      <labeller>Amgen</labeller>
      <ndc-id/>
      <ndc-product-code>55513-823</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-08-27</started-marketing-on>
      <ended-marketing-on>2008-08-27</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength>40000 1/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Epogen</name>
      <labeller>AMGEN INC</labeller>
      <ndc-id/>
      <ndc-product-code>55513-126</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1989-06-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>2000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA103234</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Epogen</name>
      <labeller>AMGEN INC</labeller>
      <ndc-id/>
      <ndc-product-code>55513-267</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1990-04-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>3000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA103234</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Epogen</name>
      <labeller>AMGEN INC</labeller>
      <ndc-id/>
      <ndc-product-code>55513-148</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1993-08-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>4000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA103234</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Epogen</name>
      <labeller>AMGEN INC</labeller>
      <ndc-id/>
      <ndc-product-code>55513-144</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1993-08-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>10000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA103234</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Epogen</name>
      <labeller>AMGEN INC</labeller>
      <ndc-id/>
      <ndc-product-code>55513-283</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1994-12-05</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>10000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA103234</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Epogen</name>
      <labeller>AMGEN INC</labeller>
      <ndc-id/>
      <ndc-product-code>55513-478</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-03-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>20000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA103234</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/001</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>1000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/002</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>1000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/003</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>2000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/004</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>2000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/005</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>3000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/006</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>3000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/007</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>4000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/008</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>4000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/009</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>5000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/010</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>5000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/011</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/012</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/013</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/014</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/015</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/016</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/017</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/018</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/019</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/020</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/021</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/022</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/023</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/024</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/025</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/026</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/027</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/028</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/029</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>1000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/030</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>2000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/031</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>3000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/032</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>4000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/033</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>5000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/034</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/035</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/036</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/037</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/038</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/039</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/040</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/041</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eporatio</name>
      <labeller>Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/001033</ema-product-code>
      <ema-ma-number>EU/1/09/573/042</ema-ma-number>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Eprex Sterile Solution</name>
      <labeller>Janssen Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02243239</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2005-08-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Eprex Sterile Solution</name>
      <labeller>Janssen Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02288680</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-11-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Eprex Sterile Solution 10000iu/1.0ml</name>
      <labeller>Janssen Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02231587</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Eprex Sterile Solution 10000iu/ml</name>
      <labeller>Janssen Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02126591</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>2014-10-09</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Eprex Sterile Solution 1000iu/0.5ml</name>
      <labeller>Janssen Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02231583</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Eprex Sterile Solution 20000iu/ml</name>
      <labeller>Janssen Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02206072</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-10-02</started-marketing-on>
      <ended-marketing-on>2010-04-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Eprex Sterile Solution 2000iu/0.5ml</name>
      <labeller>Janssen Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02231584</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Eprex Sterile Solution 2000iu/ml</name>
      <labeller>Janssen Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02126575</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1992-12-31</started-marketing-on>
      <ended-marketing-on>2014-09-25</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Eprex Sterile Solution 3000iu/0.3ml</name>
      <labeller>Janssen Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02231585</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Eprex Sterile Solution 40000iu/ml</name>
      <labeller>Janssen Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02240722</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1999-12-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Eprex Sterile Solution 4000iu/0.4ml</name>
      <labeller>Janssen Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02231586</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Eprex Sterile Solution 4000iu/ml</name>
      <labeller>Janssen Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02126583</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>2014-10-09</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Eprex Sterile Solution 5000iu/0.5ml</name>
      <labeller>Janssen Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02243400</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2002-07-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Eprex Sterile Solution 6000 Iu/0.6 Ml</name>
      <labeller>Janssen Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02243401</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2001-02-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Eprex Sterile Solution 8000 Iu/0.8 Ml</name>
      <labeller>Janssen Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02243403</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2001-02-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Neorecormon</name>
      <labeller>Roche Registration Gmb H</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000116</ema-product-code>
      <ema-ma-number>EU/1/97/031/019</ema-ma-number>
      <started-marketing-on>1997-07-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, powder, for solution</dosage-form>
      <strength/>
      <route/>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Neorecormon</name>
      <labeller>Roche Registration Gmb H</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000116</ema-product-code>
      <ema-ma-number>EU/1/97/031/025</ema-ma-number>
      <started-marketing-on>1997-07-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Neorecormon</name>
      <labeller>Roche Registration Gmb H</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000116</ema-product-code>
      <ema-ma-number>EU/1/97/031/026</ema-ma-number>
      <started-marketing-on>1997-07-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Neorecormon</name>
      <labeller>Roche Registration Gmb H</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000116</ema-product-code>
      <ema-ma-number>EU/1/97/031/029</ema-ma-number>
      <started-marketing-on>1997-07-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Neorecormon</name>
      <labeller>Roche Registration Gmb H</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000116</ema-product-code>
      <ema-ma-number>EU/1/97/031/030</ema-ma-number>
      <started-marketing-on>1997-07-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Neorecormon</name>
      <labeller>Roche Registration Gmb H</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000116</ema-product-code>
      <ema-ma-number>EU/1/97/031/031</ema-ma-number>
      <started-marketing-on>1997-07-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Neorecormon</name>
      <labeller>Roche Registration Gmb H</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000116</ema-product-code>
      <ema-ma-number>EU/1/97/031/032</ema-ma-number>
      <started-marketing-on>1997-07-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Neorecormon</name>
      <labeller>Roche Registration Gmb H</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000116</ema-product-code>
      <ema-ma-number>EU/1/97/031/033</ema-ma-number>
      <started-marketing-on>1997-07-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Neorecormon</name>
      <labeller>Roche Registration Gmb H</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000116</ema-product-code>
      <ema-ma-number>EU/1/97/031/034</ema-ma-number>
      <started-marketing-on>1997-07-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Neorecormon</name>
      <labeller>Roche Registration Gmb H</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000116</ema-product-code>
      <ema-ma-number>EU/1/97/031/035</ema-ma-number>
      <started-marketing-on>1997-07-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Neorecormon</name>
      <labeller>Roche Registration Gmb H</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000116</ema-product-code>
      <ema-ma-number>EU/1/97/031/037</ema-ma-number>
      <started-marketing-on>1997-07-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route/>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Neorecormon</name>
      <labeller>Roche Registration Gmb H</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000116</ema-product-code>
      <ema-ma-number>EU/1/97/031/038</ema-ma-number>
      <started-marketing-on>1997-07-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route/>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Neorecormon</name>
      <labeller>Roche Registration Gmb H</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000116</ema-product-code>
      <ema-ma-number>EU/1/97/031/041</ema-ma-number>
      <started-marketing-on>1997-07-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route/>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Neorecormon</name>
      <labeller>Roche Registration Gmb H</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000116</ema-product-code>
      <ema-ma-number>EU/1/97/031/042</ema-ma-number>
      <started-marketing-on>1997-07-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route/>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Neorecormon</name>
      <labeller>Roche Registration Gmb H</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000116</ema-product-code>
      <ema-ma-number>EU/1/97/031/043</ema-ma-number>
      <started-marketing-on>1997-07-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route/>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Neorecormon</name>
      <labeller>Roche Registration Gmb H</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000116</ema-product-code>
      <ema-ma-number>EU/1/97/031/044</ema-ma-number>
      <started-marketing-on>1997-07-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route/>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Neorecormon</name>
      <labeller>Roche Registration Gmb H</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000116</ema-product-code>
      <ema-ma-number>EU/1/97/031/045</ema-ma-number>
      <started-marketing-on>1997-07-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route/>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Neorecormon Guard</name>
      <labeller>Roche Registration Gmb H</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000116</ema-product-code>
      <ema-ma-number>EU/1/97/031/036</ema-ma-number>
      <started-marketing-on>1997-07-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Neorecormon Guard</name>
      <labeller>Roche Registration Gmb H</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000116</ema-product-code>
      <ema-ma-number>EU/1/97/031/046</ema-ma-number>
      <started-marketing-on>1997-07-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Procrit</name>
      <labeller>Physicians Total Care, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>54868-2523</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1994-08-11</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA103234</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Procrit</name>
      <labeller>Physicians Total Care, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>54868-5802</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-08-13</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>40000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA103234</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Procrit</name>
      <labeller>Physicians Total Care, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>54868-5673</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-03-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA103234</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Procrit</name>
      <labeller>Janssen Products, LP</labeller>
      <ndc-id/>
      <ndc-product-code>59676-302</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1989-06-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>2000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA103234</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Procrit</name>
      <labeller>Janssen Products, LP</labeller>
      <ndc-id/>
      <ndc-product-code>59676-303</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1989-06-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>3000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA103234</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Procrit</name>
      <labeller>Janssen Products, LP</labeller>
      <ndc-id/>
      <ndc-product-code>59676-304</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1989-06-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>4000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA103234</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Procrit</name>
      <labeller>Janssen Products, LP</labeller>
      <ndc-id/>
      <ndc-product-code>59676-310</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1989-06-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA103234</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Procrit</name>
      <labeller>Janssen Products, LP</labeller>
      <ndc-id/>
      <ndc-product-code>59676-340</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1989-06-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>40000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA103234</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Procrit</name>
      <labeller>Janssen Products, LP</labeller>
      <ndc-id/>
      <ndc-product-code>59676-312</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1989-06-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA103234</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Procrit</name>
      <labeller>Janssen Products, LP</labeller>
      <ndc-id/>
      <ndc-product-code>59676-320</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1989-06-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA103234</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Vifor (International) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>59353-002</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-06-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>2000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA125545</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Vifor (International) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>59353-003</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-06-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>3000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA125545</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Vifor (International) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>59353-004</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-06-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>4000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA125545</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Vifor (International) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>59353-010</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-06-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA125545</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Laboratories Div Pfizer Inc</labeller>
      <ndc-id/>
      <ndc-product-code>0069-1305</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-06-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>2000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA125545</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Laboratories Div Pfizer Inc</labeller>
      <ndc-id/>
      <ndc-product-code>0069-1306</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-06-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>3000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA125545</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Laboratories Div Pfizer Inc</labeller>
      <ndc-id/>
      <ndc-product-code>0069-1307</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-06-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>4000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA125545</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Laboratories Div Pfizer Inc</labeller>
      <ndc-id/>
      <ndc-product-code>0069-1308</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-06-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA125545</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Laboratories Div Pfizer Inc</labeller>
      <ndc-id/>
      <ndc-product-code>0069-1309</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-06-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>40000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA125545</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Vifor (International) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>59353-120</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2020-09-11</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA125545</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Vifor (International) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>59353-220</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2020-09-11</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA125545</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Laboratories Div Pfizer Inc</labeller>
      <ndc-id/>
      <ndc-product-code>0069-1311</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2020-11-09</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA125545</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Laboratories Div Pfizer Inc</labeller>
      <ndc-id/>
      <ndc-product-code>0069-1318</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2020-11-09</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 [iU]/1mL</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number>BLA125545</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/001</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/002</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/003</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/004</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/005</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/006</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/007</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/008</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/009</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/010</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/011</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/012</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/013</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/014</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/015</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/016</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/017</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/018</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/019</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/020</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/021</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/022</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/023</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/024</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/025</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/026</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/027</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/028</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/029</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/030</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/031</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/032</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/033</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/035</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/036</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/037</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/038</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/039</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/040</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/041</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/042</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/043</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/044</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/045</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/046</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/048</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/049</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/050</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/051</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/052</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/053</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/054</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/055</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/056</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/057</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/058</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/060</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/061</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/062</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/063</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/064</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/065</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/066</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/067</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/068</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/069</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/070</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/071</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/073</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/074</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/075</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/076</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/077</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/034</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/047</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/059</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/072</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Retacrit</name>
      <labeller>Pfizer Europe Ma Eeig</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000872</ema-product-code>
      <ema-ma-number>EU/1/07/431/078</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/001</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>1000 IU/0.3ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/002</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>1000 IU/0.3ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/003</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>2000 IU/0.6ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/004</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>2000 IU/0.6ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/005</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>3000 IU/0.9ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/006</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>3000 IU/0.9ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/007</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>4000 IU/0.4ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/008</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>4000 IU/0.4ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/009</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>5000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/010</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>5000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/011</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>6000 IU/0.6ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/012</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>6000 IU/0.6ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/013</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>8000 IU/0.8ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/014</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>8000 IU/0.8ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/015</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/016</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>10000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/017</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/018</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/0.75ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/019</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>40000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/020</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>20000 IU/0.5ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/021</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>30000 IU/0.75ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/022</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>40000 IU/1.0ml</strength>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/023</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/024</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/025</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/026</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/027</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/028</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/029</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/030</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/031</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/032</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/033</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/034</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/035</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/036</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/037</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/038</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/039</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/040</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/041</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/042</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/043</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/044</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/045</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/046</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Silapo</name>
      <labeller>Stada Arzneimittel Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000760</ema-product-code>
      <ema-ma-number>EU/1/07/432/047</ema-ma-number>
      <started-marketing-on>2007-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous; Subcutaneous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
  </products>
  <international-brands>
    <international-brand>
      <name>Epobel</name>
      <company>Nobel Ilac Pazarlama ve Sanayii Ltd. STI., Turkey</company>
    </international-brand>
    <international-brand>
      <name>Epocept</name>
      <company>Lupin pharma</company>
    </international-brand>
    <international-brand>
      <name>Epofit</name>
      <company>Intas pharma</company>
    </international-brand>
    <international-brand>
      <name>Epogin</name>
      <company>Chugai</company>
    </international-brand>
    <international-brand>
      <name>Eqralys</name>
      <company>Hemofarm AD</company>
    </international-brand>
    <international-brand>
      <name>Nanokine</name>
      <company>Nanogen Pharmaceutical biotechnology, Vietnam)</company>
    </international-brand>
  </international-brands>
  <mixtures>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Abseamed</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Binocrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eporatio</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Biopoin</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Procrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Procrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Procrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epogen</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epogen</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epogen</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epogen</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epogen</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epogen</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epogen</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Procrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Procrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Procrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Procrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Procrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Procrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Procrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Neorecormon</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Neorecormon</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Neorecormon</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Neorecormon</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Neorecormon</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Neorecormon</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Neorecormon</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Neorecormon</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Neorecormon</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Neorecormon</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Neorecormon Guard</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Neorecormon</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Neorecormon</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Neorecormon</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Neorecormon</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Neorecormon</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Neorecormon</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Neorecormon</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Neorecormon Guard</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Silapo</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Epoetin Alfa Hexal</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Retacrit</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eprex Sterile Solution 1000iu/0.5ml</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eprex Sterile Solution 2000iu/0.5ml</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eprex Sterile Solution 3000iu/0.3ml</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eprex Sterile Solution 4000iu/0.4ml</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eprex Sterile Solution 10000iu/1.0ml</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eprex Sterile Solution 40000iu/ml</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eprex Sterile Solution</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eprex Sterile Solution 5000iu/0.5ml</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eprex Sterile Solution 6000 Iu/0.6 Ml</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eprex Sterile Solution 8000 Iu/0.8 Ml</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eprex Sterile Solution</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eprex Sterile Solution 10000iu/ml</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eprex Sterile Solution 4000iu/ml</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eprex Sterile Solution 2000iu/ml</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
    <mixture>
      <name>Eprex Sterile Solution 20000iu/ml</name>
      <ingredients>Erythropoietin</ingredients>
    </mixture>
  </mixtures>
  <packagers>
    <packager>
      <name>Amgen Inc.</name>
      <url>http://www.amgen.com</url>
    </packager>
    <packager>
      <name>Centocor Ortho Biotech Inc.</name>
      <url>http://www.centocororthobiotech.com</url>
    </packager>
    <packager>
      <name>DSM Corp.</name>
      <url>http://www.dsm.com</url>
    </packager>
    <packager>
      <name>Janssen-Ortho Inc.</name>
      <url>http://www.janssen-ortho.com</url>
    </packager>
    <packager>
      <name>JHP Pharmaceuticals LLC</name>
      <url>http://www.jhppharma.com</url>
    </packager>
    <packager>
      <name>Ortho-McNeil-Janssen Pharmaceuticals Inc.</name>
      <url>http://www.ortho-mcneil.com</url>
    </packager>
    <packager>
      <name>Physicians Total Care Inc.</name>
      <url>http://www.physicianstotalcare.com</url>
    </packager>
  </packagers>
  <manufacturers/>
  <prices>
    <price>
      <description>Epogen 2000 unit/ml vial</description>
      <cost currency="USD">34.14</cost>
      <unit>vial</unit>
    </price>
    <price>
      <description>Procrit 2000 unit/ml vial</description>
      <cost currency="USD">37.09</cost>
      <unit>vial</unit>
    </price>
    <price>
      <description>Epogen 3000 unit/ml vial</description>
      <cost currency="USD">47.53</cost>
      <unit>vial</unit>
    </price>
    <price>
      <description>Procrit 3000 unit/ml vial</description>
      <cost currency="USD">55.63</cost>
      <unit>vial</unit>
    </price>
    <price>
      <description>Epogen 4000 unit/ml vial</description>
      <cost currency="USD">61.34</cost>
      <unit>vial</unit>
    </price>
    <price>
      <description>Procrit 4000 unit/ml vial</description>
      <cost currency="USD">74.17</cost>
      <unit>vial</unit>
    </price>
    <price>
      <description>Epogen 10000 unit/ml vial</description>
      <cost currency="USD">151.8</cost>
      <unit>ml</unit>
    </price>
    <price>
      <description>Epogen 20000 unit/ml vial</description>
      <cost currency="USD">303.6</cost>
      <unit>ml</unit>
    </price>
    <price>
      <description>Epogen 10000 unit/ml Solution 2ml Vial</description>
      <cost currency="USD">315.74</cost>
      <unit>vial</unit>
    </price>
    <price>
      <description>Procrit 10000 unit/ml Solution 2ml Vial</description>
      <cost currency="USD">358.02</cost>
      <unit>vial</unit>
    </price>
    <price>
      <description>Procrit 20000 unit/ml Solution</description>
      <cost currency="USD">378.14</cost>
      <unit>ml</unit>
    </price>
    <price>
      <description>Procrit 20000 unit/ml vial</description>
      <cost currency="USD">388.97</cost>
      <unit>ml</unit>
    </price>
    <price>
      <description>Epogen 40000 unit/ml vial</description>
      <cost currency="USD">640.37</cost>
      <unit>ml</unit>
    </price>
    <price>
      <description>Procrit 10000 unit/ml vial</description>
      <cost currency="USD">710.87</cost>
      <unit>vial</unit>
    </price>
    <price>
      <description>Procrit 40000 unit/ml vial</description>
      <cost currency="USD">767.03</cost>
      <unit>vial</unit>
    </price>
    <price>
      <description>Epogen 10000 unit/ml Solution 1 Box Contains Ten 1ml Vials</description>
      <cost currency="USD">1578.72</cost>
      <unit>box</unit>
    </price>
    <price>
      <description>Epogen 20000 unit/ml Solution 1 Box Contains Ten 1ml Vials</description>
      <cost currency="USD">3157.44</cost>
      <unit>box</unit>
    </price>
    <price>
      <description>Epogen 40000 unit/ml Solution 1 Box Contains Ten 1ml Vials</description>
      <cost currency="USD">6852.3</cost>
      <unit>box</unit>
    </price>
  </prices>
  <categories>
    <category>
      <category>Amino Acids, Peptides, and Proteins</category>
      <mesh-id>D000602</mesh-id>
    </category>
    <category>
      <category>Antianemic Preparations</category>
      <mesh-id/>
    </category>
    <category>
      <category>Biological Factors</category>
      <mesh-id>D001685</mesh-id>
    </category>
    <category>
      <category>Blood and Blood Forming Organs</category>
      <mesh-id/>
    </category>
    <category>
      <category>Carbohydrates</category>
      <mesh-id>D002241</mesh-id>
    </category>
    <category>
      <category>Colony-Stimulating Factors</category>
      <mesh-id>D003115</mesh-id>
    </category>
    <category>
      <category>Cytokines</category>
      <mesh-id>D016207</mesh-id>
    </category>
    <category>
      <category>Erythropoiesis-Stimulating Agents</category>
      <mesh-id/>
    </category>
    <category>
      <category>Erythropoietin, genetics</category>
      <mesh-id/>
    </category>
    <category>
      <category>Glycoconjugates</category>
      <mesh-id>D006001</mesh-id>
    </category>
    <category>
      <category>Glycoproteins</category>
      <mesh-id>D006023</mesh-id>
    </category>
    <category>
      <category>Hematinics</category>
      <mesh-id>D006397</mesh-id>
    </category>
    <category>
      <category>Hematologic Agents</category>
      <mesh-id>D006401</mesh-id>
    </category>
    <category>
      <category>Hematopoietic Cell Growth Factors</category>
      <mesh-id>D016298</mesh-id>
    </category>
    <category>
      <category>Increased Erythroid Cell Production</category>
      <mesh-id/>
    </category>
    <category>
      <category>Intercellular Signaling Peptides and Proteins</category>
      <mesh-id>D036341</mesh-id>
    </category>
    <category>
      <category>Peptides</category>
      <mesh-id>D010455</mesh-id>
    </category>
    <category>
      <category>Proteins</category>
      <mesh-id>D011506</mesh-id>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>1000 UI/0.5ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>10000 UI/1.0ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>3000 UI/0.3ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>4000 UI/0.4ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>5000 UI/0.5ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>6000 UI/0.6ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>8000 UI/0.8ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>1000 IU/0.5ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>10000 IU/1.0ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>2000 IU/1.0ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>20000 IU/0.5ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>3000 IU/0.3ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>30000 IU/0.75ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>4000 IU/0.4ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>40000 IU/1ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>40000 IU/1.0ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>5000 IU/0.5ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>6000 IU/0.6ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>7000 IU/0.7ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>8000 IU/0.8ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>9000 IU/0.9ml</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>1000 UI/0.5ML</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>2000 UI/1.0ML</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>3000 UI/0.3ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>10000 I.E./1ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>1000 I.E./0.5ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>2000 I.E./1ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>3000 I.E./0.3ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>4000 I.E./0.4ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>5000 I.E./0.5ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>6000 I.E./0.6ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>8000 I.E./0.8ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>20000 UI/0.5ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>30000 UI/0.75ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>40000 UI/1.0ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>10000 IU/1ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>3000 IU/3.0ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Subcutaneous</route>
      <strength>7000 UI/0.7ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Subcutaneous</route>
      <strength>9000 UI/0.9ML</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>1000 UI/0.5ML</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>10000 UI/1ML</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>2000 UI/1ML</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>20000 UI/0.5ML</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>3000 UI/0.3ML</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>30000 UI/0.75ML</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>4000 UI/0.4ML</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>40000 UI/1ML</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>5000 UI/0.5ML</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>6000 UI/0.6ML</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>7000 UI/0.7ML</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>8000 UI/0.8ML</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>9000 UI/0.9ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>10.000 I.E./1ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>2000 IU/ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>2.000 I.E./1.0ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>2000 iu/1ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>2000 IE/1ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>3.000 I.E./0.3ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>4.000 I.E./0.4ML</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>40000 IU/ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>40.000 I.E./1ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>40.000 IE/1ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>40000 I.E./1ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>5.000 I.E./0.5ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>6.000 I.E./0.6ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>8.000 I.E./0.8ML</strength>
    </dosage>
    <dosage>
      <form>Injection, powder, for solution</form>
      <route/>
      <strength>2000 iu</strength>
    </dosage>
    <dosage>
      <form>Injection, powder, for solution</form>
      <route/>
      <strength>4000 iu</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>2000 iu/0.2ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>3000 iu/0.3ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>4000 iu/0.4ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>10000 iu/1mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>2000 iu/1mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>3000 iu/1mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>4000 iu/1mL</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>10000 IU/ml</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>2000 IU/0.6ml</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>4000 IU/0.4ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>1000 iu/0.3ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>10000 iu/1.0ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>2000 iu/0.6ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>3000 iu/0.9ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>4000 iu/0.4ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>5000 iu/0.5ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>6000 iu/0.6ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>8000 iu/0.8ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route/>
      <strength>10000 IU/ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>10000 IE</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>1000 IE</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>20000 IE</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>2000 IE</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>30000 IE</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>3000 IE</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>40000 IE</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>4000 IE</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>5000 IE</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>6000 IE</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>8000 IE</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>10000 [iU]/1mL</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>2000 [iU]/1mL</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>20000 [iU]/1mL</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>3000 [iU]/1mL</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>4000 [iU]/1mL</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>40000 1/1mL</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route/>
      <strength>6000 IU/ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>2000 iu/ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>4000 iu/ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>10000 UI/1.0ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>20000 UI/1.0ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>30000 UI/1.0ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>2000 IU/0.5ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>20000 IU/1.0ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>3000 IU/0.5ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>30000 IU/1.0ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>4000 IU/0.5ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>1000 IE/0.5ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>10000 IE/1.0ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>2000 IE/0.5ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>20000 IE/1ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>3000 IE/0.5ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>30000 IE/1.0ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>4000 IE/0.5ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>0.5 ML</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>10000 iu/1.0ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>2000 iu/0.5ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>4000 iu/0.4ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route/>
      <strength>10000 IU</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route/>
      <strength>4000 IU</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>500 UI</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>5000 UI/0.5ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>6000 UI/0.6ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>7000 UI/0.7ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>8000 UI/0.8ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>9000 UI/0.9ML</strength>
    </dosage>
    <dosage>
      <form>Injection, powder, lyophilized, for solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>1000 IU</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>2000 iu/0.5mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>20000 iu/0.5mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>3000 iu/0.3mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>30000 UI/0.75ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>30000 iu/0.75mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>4000 iu/0.4mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>40000 UI/ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>40000 UI</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>40000 iu/1mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>5000 iu/0.5mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>6000 iu/0.6mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>8000 iu/0.8mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>10000 IU/ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>2000 IU/ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>4000 IU/ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>500 IU/0.25ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>40000 IU/ML</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>1000 iu/0.5ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>10000 iu/ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route/>
      <strength>2000 IU/0.5ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>3000 iu/0.3ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route/>
      <strength>4000 IU/0.4ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route/>
      <strength>40000 IU/ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>40000 IU/ML</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>10000 IU</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>2000 IU</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>40000 IU</strength>
    </dosage>
    <dosage>
      <form>Injection, powder, lyophilized, for solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>2000 IU</strength>
    </dosage>
    <dosage>
      <form>Injection, powder, lyophilized, for solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>4000 IU</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>4000 IU</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Parenteral</route>
      <strength>2000 IU</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Parenteral</route>
      <strength>1000 I.E./0.5ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Parenteral</route>
      <strength>10000 I.E./ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Parenteral</route>
      <strength>2000 I.E./0.5ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Parenteral</route>
      <strength>4000 I.E./0.4ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Parenteral</route>
      <strength>40000 I.E./ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Parenteral</route>
      <strength>6000 I.E./0.6ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>1000 IU</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>10000 IU</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>2000 IU</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>20000 I.E./0.5ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>3000 IU</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>30000 I.E./0.75ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>4000 IU</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>40000 I.E./ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>5000 IU</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>6000 IU</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>8000 IU</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>2000 IU/0.5ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route/>
      <strength>3000 IU</strength>
    </dosage>
    <dosage>
      <form>Injection, powder, for solution</form>
      <route/>
      <strength>10000 iu</strength>
    </dosage>
    <dosage>
      <form>Injection, powder, for solution</form>
      <route/>
      <strength>3000 iu</strength>
    </dosage>
    <dosage>
      <form>Injection, powder, for solution</form>
      <route/>
      <strength>1000 iu</strength>
    </dosage>
    <dosage>
      <form>Injection, powder, for solution</form>
      <route/>
      <strength/>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength/>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>1000 IU/0.3ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>10000 IU/0.6ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>10000 IU</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>2000 IU/0.3ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>20000 IU/0.6ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>3000 IU/0.3ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>4000 IU/0.3ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>500 IU/0.3ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>5000 IU/0.3ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>6000 IU/0.3ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral; Subcutaneous</route>
      <strength>2000 IU/0.3ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>30000 IU</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral; Subcutaneous</route>
      <strength>4000 IU</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral; Subcutaneous</route>
      <strength>6000 IU</strength>
    </dosage>
    <dosage>
      <form>Powder</form>
      <route>Intravenous</route>
      <strength>1000 UI</strength>
    </dosage>
    <dosage>
      <form>Powder</form>
      <route>Intravenous</route>
      <strength>10000 UI</strength>
    </dosage>
    <dosage>
      <form>Powder</form>
      <route>Intravenous</route>
      <strength>2000 UI</strength>
    </dosage>
    <dosage>
      <form>Powder</form>
      <route>Intravenous</route>
      <strength>500 UI</strength>
    </dosage>
    <dosage>
      <form>Powder</form>
      <route>Intravenous</route>
      <strength>5000 UI</strength>
    </dosage>
    <dosage>
      <form>Powder</form>
      <route>Parenteral</route>
      <strength>100000 IU/ml</strength>
    </dosage>
    <dosage>
      <form>Powder</form>
      <route>Parenteral</route>
      <strength>50000 IU/ml</strength>
    </dosage>
    <dosage>
      <form>Powder</form>
      <route>Subcutaneous</route>
      <strength>10000 UI</strength>
    </dosage>
    <dosage>
      <form>Powder</form>
      <route>Subcutaneous</route>
      <strength>20000 UI</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>10.000 I.E.</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>10000 iu/0.6ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>10000 IU/0.6ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>2000 iu/0.3ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>20000 iu/0.6ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>2000 IU/0.3ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>3000 IU/0.3ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>4000 IU/0.3ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>5000 IU/0.3ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>5000 iu/0.3ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>500 IU/0.3ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>6000 IU/0.3ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>10000 [iU]/1mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>2000 [iU]/1mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>20000 [iU]/1mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>3000 [iU]/1mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>4000 [iU]/1mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>40000 [iU]/1mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>2000 iu</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>4000 iu</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>1000 iu/0.5mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>10000 iu/0.6mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>2000 iu/0.3mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>30000 iu/0.6mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>4000 iu/0.3mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>5000 iu/0.3mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>6000 iu/0.3mL</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route/>
      <strength>2000 IU</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route/>
      <strength>30000 IU</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route/>
      <strength>5000 IU</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>2000 iu/0.3ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>4000 iu/0.3ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>5000 iu/0.3ml</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Parenteral</route>
      <strength>1000 IU</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>500 IU</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>5000 IU</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>30000 IU</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route/>
      <strength>12000 IU/0.5ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route/>
      <strength>2000 IU/ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route/>
      <strength>3000 IU/ML</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route/>
      <strength>4000 IU/ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>1000 UI/0.3ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>10000 IU/1.0ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>2000 IU/0.6ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>2000 UI/0.6ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>20000 UI/0.5ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>20000 IU/0.5ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>3000 IU/0.9ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>3000 UI/0.9ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>30000 IU/0.75ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>30000 UI/0.75ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>4000 IU/0.4ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>4000 UI/0.4ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>40000 UI/1.0ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>40000 IU/1.0ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>5000 IU/0.5ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>5000 UI/0.5ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>6000 IU/0.6ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>6000 UI/0.6ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>8000 IU/0.8ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Parenteral</route>
      <strength>8000 UI/0.8ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>10.000 I.E./1.0ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>10000 I.E./1.0ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>1000 IE/0.3ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>2.000 I.E./0.6ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>2000 I.E./0.6ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>20000 IE/0.5ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>2000 IE/0.6ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>3.000 I.E./0.9ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>30.000 IE/0.75ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>3000 I.E./0.9ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>30000 IE/0.75ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>3000 IE/0.9ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>4.000 IE/0.4ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>40.000 I.E./1.0ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>40000 I.E./1.0ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>40000 IE/1.0ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>4000 IE/0.4ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>5000 IE/0.5ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>6.000 IE/0.6ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>6000 IE/0.6ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Parenteral</route>
      <strength>8000 IE/0.8ML</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>1000 IU/0.3ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>2000 IU/0.6ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous; Subcutaneous</route>
      <strength>3000 IU/0.9ml</strength>
    </dosage>
  </dosages>
  <atc-codes>
    <atc-code code="B03XA01">
      <level code="B03XA">Other antianemic preparations</level>
      <level code="B03X">OTHER ANTIANEMIC PREPARATIONS</level>
      <level code="B03">ANTIANEMIC PREPARATIONS</level>
      <level code="B">BLOOD AND BLOOD FORMING ORGANS</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes>
    <ahfs-code>20:16.00</ahfs-code>
  </ahfs-codes>
  <pdb-entries/>
  <fda-label>//s3-us-west-2.amazonaws.com/drugbank/fda_labels/DB00016.pdf?1526572503</fda-label>
  <patents>
    <patent>
      <number>1339047</number>
      <country>Canada</country>
      <approved>1997-05-27</approved>
      <expires>2014-05-27</expires>
      <pediatric-extension>false</pediatric-extension>
    </patent>
  </patents>
  <food-interactions/>
  <drug-interactions>
    <drug-interaction>
      <drugbank-id>DB00480</drugbank-id>
      <name>Lenalidomide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lenalidomide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01041</drugbank-id>
      <name>Thalidomide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Thalidomide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08910</drugbank-id>
      <name>Pomalidomide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pomalidomide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00002</drugbank-id>
      <name>Cetuximab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cetuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00004</drugbank-id>
      <name>Denileukin diftitox</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Denileukin diftitox.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00007</drugbank-id>
      <name>Leuprolide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Leuprolide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00008</drugbank-id>
      <name>Peginterferon alfa-2a</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Peginterferon alfa-2a.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00014</drugbank-id>
      <name>Goserelin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Goserelin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00023</drugbank-id>
      <name>Asparaginase Escherichia coli</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Asparaginase Escherichia coli.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00041</drugbank-id>
      <name>Aldesleukin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Aldesleukin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00056</drugbank-id>
      <name>Gemtuzumab ozogamicin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gemtuzumab ozogamicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00059</drugbank-id>
      <name>Pegaspargase</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pegaspargase.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00072</drugbank-id>
      <name>Trastuzumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trastuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00073</drugbank-id>
      <name>Rituximab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rituximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00081</drugbank-id>
      <name>Tositumomab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tositumomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00087</drugbank-id>
      <name>Alemtuzumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alemtuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00104</drugbank-id>
      <name>Octreotide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Octreotide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00105</drugbank-id>
      <name>Interferon alfa-2b</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Interferon alfa-2b.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00112</drugbank-id>
      <name>Bevacizumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bevacizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00179</drugbank-id>
      <name>Masoprocol</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Masoprocol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00188</drugbank-id>
      <name>Bortezomib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bortezomib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00236</drugbank-id>
      <name>Pipobroman</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pipobroman.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00242</drugbank-id>
      <name>Cladribine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cladribine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00248</drugbank-id>
      <name>Cabergoline</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cabergoline.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00261</drugbank-id>
      <name>Anagrelide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Anagrelide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00262</drugbank-id>
      <name>Carmustine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Carmustine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00269</drugbank-id>
      <name>Chlorotrianisene</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Chlorotrianisene.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00276</drugbank-id>
      <name>Amsacrine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Amsacrine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00282</drugbank-id>
      <name>Pamidronic acid</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pamidronic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00290</drugbank-id>
      <name>Bleomycin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bleomycin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00291</drugbank-id>
      <name>Chlorambucil</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Chlorambucil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00293</drugbank-id>
      <name>Raltitrexed</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Raltitrexed.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00305</drugbank-id>
      <name>Mitomycin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mitomycin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00307</drugbank-id>
      <name>Bexarotene</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bexarotene.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00313</drugbank-id>
      <name>Valproic acid</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Valproic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00317</drugbank-id>
      <name>Gefitinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gefitinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00322</drugbank-id>
      <name>Floxuridine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Floxuridine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00351</drugbank-id>
      <name>Megestrol acetate</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Megestrol acetate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00352</drugbank-id>
      <name>Tioguanine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tioguanine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00357</drugbank-id>
      <name>Aminoglutethimide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Aminoglutethimide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00385</drugbank-id>
      <name>Valrubicin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Valrubicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00398</drugbank-id>
      <name>Sorafenib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sorafenib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00428</drugbank-id>
      <name>Streptozocin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Streptozocin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00432</drugbank-id>
      <name>Trifluridine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trifluridine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00441</drugbank-id>
      <name>Gemcitabine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gemcitabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00444</drugbank-id>
      <name>Teniposide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Teniposide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00445</drugbank-id>
      <name>Epirubicin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Epirubicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00488</drugbank-id>
      <name>Altretamine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Altretamine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00499</drugbank-id>
      <name>Flutamide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Flutamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00515</drugbank-id>
      <name>Cisplatin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cisplatin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00523</drugbank-id>
      <name>Alitretinoin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alitretinoin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00526</drugbank-id>
      <name>Oxaliplatin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Oxaliplatin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00530</drugbank-id>
      <name>Erlotinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Erlotinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00539</drugbank-id>
      <name>Toremifene</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Toremifene.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00544</drugbank-id>
      <name>Fluorouracil</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fluorouracil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00552</drugbank-id>
      <name>Pentostatin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pentostatin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00563</drugbank-id>
      <name>Methotrexate</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Methotrexate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00603</drugbank-id>
      <name>Medroxyprogesterone acetate</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Medroxyprogesterone acetate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00619</drugbank-id>
      <name>Imatinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Imatinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00631</drugbank-id>
      <name>Clofarabine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Clofarabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00635</drugbank-id>
      <name>Prednisone</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Prednisone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00642</drugbank-id>
      <name>Pemetrexed</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pemetrexed.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00648</drugbank-id>
      <name>Mitotane</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mitotane.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00665</drugbank-id>
      <name>Nilutamide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nilutamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00675</drugbank-id>
      <name>Tamoxifen</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tamoxifen.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00694</drugbank-id>
      <name>Daunorubicin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Daunorubicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00707</drugbank-id>
      <name>Porfimer sodium</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Porfimer sodium.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00755</drugbank-id>
      <name>Tretinoin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tretinoin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00762</drugbank-id>
      <name>Irinotecan</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Irinotecan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00773</drugbank-id>
      <name>Etoposide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Etoposide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00791</drugbank-id>
      <name>Uracil mustard</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Uracil mustard.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00851</drugbank-id>
      <name>Dacarbazine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dacarbazine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00853</drugbank-id>
      <name>Temozolomide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Temozolomide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00855</drugbank-id>
      <name>Aminolevulinic acid</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Aminolevulinic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00860</drugbank-id>
      <name>Prednisolone</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Prednisolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00888</drugbank-id>
      <name>Mechlorethamine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mechlorethamine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00894</drugbank-id>
      <name>Testolactone</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Testolactone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00928</drugbank-id>
      <name>Azacitidine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Azacitidine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00947</drugbank-id>
      <name>Fulvestrant</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fulvestrant.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00958</drugbank-id>
      <name>Carboplatin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Carboplatin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00959</drugbank-id>
      <name>Methylprednisolone</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Methylprednisolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00970</drugbank-id>
      <name>Dactinomycin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dactinomycin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00987</drugbank-id>
      <name>Cytarabine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cytarabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00990</drugbank-id>
      <name>Exemestane</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Exemestane.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00997</drugbank-id>
      <name>Doxorubicin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Doxorubicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01005</drugbank-id>
      <name>Hydroxyurea</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Hydroxyurea.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01006</drugbank-id>
      <name>Letrozole</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Letrozole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01008</drugbank-id>
      <name>Busulfan</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Busulfan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01030</drugbank-id>
      <name>Topotecan</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Topotecan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01033</drugbank-id>
      <name>Mercaptopurine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mercaptopurine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01042</drugbank-id>
      <name>Melphalan</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Melphalan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01073</drugbank-id>
      <name>Fludarabine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fludarabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01101</drugbank-id>
      <name>Capecitabine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Capecitabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01108</drugbank-id>
      <name>Trilostane</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trilostane.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01128</drugbank-id>
      <name>Bicalutamide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bicalutamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01157</drugbank-id>
      <name>Trimetrexate</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trimetrexate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01168</drugbank-id>
      <name>Procarbazine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Procarbazine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01169</drugbank-id>
      <name>Arsenic trioxide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Arsenic trioxide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01177</drugbank-id>
      <name>Idarubicin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Idarubicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01181</drugbank-id>
      <name>Ifosfamide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ifosfamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01196</drugbank-id>
      <name>Estramustine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Estramustine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01204</drugbank-id>
      <name>Mitoxantrone</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mitoxantrone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01206</drugbank-id>
      <name>Lomustine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lomustine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01217</drugbank-id>
      <name>Anastrozole</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Anastrozole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01229</drugbank-id>
      <name>Paclitaxel</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Paclitaxel.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01234</drugbank-id>
      <name>Dexamethasone</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dexamethasone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01248</drugbank-id>
      <name>Docetaxel</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Docetaxel.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01254</drugbank-id>
      <name>Dasatinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dasatinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01259</drugbank-id>
      <name>Lapatinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lapatinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01262</drugbank-id>
      <name>Decitabine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Decitabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01268</drugbank-id>
      <name>Sunitinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sunitinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01269</drugbank-id>
      <name>Panitumumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Panitumumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01280</drugbank-id>
      <name>Nelarabine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nelarabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01590</drugbank-id>
      <name>Everolimus</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Everolimus.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01645</drugbank-id>
      <name>Genistein</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Genistein.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01667</drugbank-id>
      <name>8-azaguanine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 8-azaguanine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01873</drugbank-id>
      <name>Epothilone D</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Epothilone D.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01933</drugbank-id>
      <name>7-Hydroxystaurosporine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 7-Hydroxystaurosporine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02109</drugbank-id>
      <name>Hadacidin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Hadacidin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02342</drugbank-id>
      <name>2-Methoxyestradiol</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 2-Methoxyestradiol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02424</drugbank-id>
      <name>Geldanamycin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Geldanamycin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02546</drugbank-id>
      <name>Vorinostat</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vorinostat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02640</drugbank-id>
      <name>Fumagillin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fumagillin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03010</drugbank-id>
      <name>Patupilone</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Patupilone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03172</drugbank-id>
      <name>Tubercidin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tubercidin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03459</drugbank-id>
      <name>Sparfosic acid</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sparfosic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03496</drugbank-id>
      <name>Alvocidib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alvocidib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03509</drugbank-id>
      <name>2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03523</drugbank-id>
      <name>Brequinar</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Brequinar.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03695</drugbank-id>
      <name>Piritrexim</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Piritrexim.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03825</drugbank-id>
      <name>Rhodamine 6G</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rhodamine 6G.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03880</drugbank-id>
      <name>Batimastat</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Batimastat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03946</drugbank-id>
      <name>3,4-Dihydroxybenzoic Acid</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 3,4-Dihydroxybenzoic Acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04106</drugbank-id>
      <name>Fotemustine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fotemustine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04222</drugbank-id>
      <name>Sparsomycin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sparsomycin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04253</drugbank-id>
      <name>Tretazicar</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tretazicar.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04258</drugbank-id>
      <name>Seocalcitol</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Seocalcitol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04331</drugbank-id>
      <name>Monastrol</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Monastrol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04440</drugbank-id>
      <name>Nebularine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nebularine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04468</drugbank-id>
      <name>Afimoxifene</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Afimoxifene.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04572</drugbank-id>
      <name>Thiotepa</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Thiotepa.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04576</drugbank-id>
      <name>Fleroxacin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fleroxacin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04655</drugbank-id>
      <name>Metoprine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Metoprine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04690</drugbank-id>
      <name>Camptothecin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Camptothecin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04786</drugbank-id>
      <name>Suramin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Suramin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04827</drugbank-id>
      <name>Urethane</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Urethane.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04839</drugbank-id>
      <name>Cyproterone acetate</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cyproterone acetate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04845</drugbank-id>
      <name>Ixabepilone</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ixabepilone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04849</drugbank-id>
      <name>Cediranib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cediranib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04858</drugbank-id>
      <name>Tirapazamine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tirapazamine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04865</drugbank-id>
      <name>Omacetaxine mepesuccinate</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Omacetaxine mepesuccinate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04866</drugbank-id>
      <name>Halofuginone</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Halofuginone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04868</drugbank-id>
      <name>Nilotinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nilotinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04894</drugbank-id>
      <name>Vapreotide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vapreotide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04900</drugbank-id>
      <name>Thymalfasin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Thymalfasin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04901</drugbank-id>
      <name>Galiximab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Galiximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04907</drugbank-id>
      <name>Sitimagene ceradenovec</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sitimagene ceradenovec.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04950</drugbank-id>
      <name>Ranpirnase</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ranpirnase.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04951</drugbank-id>
      <name>Pirfenidone</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pirfenidone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04958</drugbank-id>
      <name>Epratuzumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Epratuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04960</drugbank-id>
      <name>Tipifarnib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tipifarnib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04961</drugbank-id>
      <name>Troxacitabine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Troxacitabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04964</drugbank-id>
      <name>Oregovomab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Oregovomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04975</drugbank-id>
      <name>Banoxantrone</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Banoxantrone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04977</drugbank-id>
      <name>Plitidepsin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Plitidepsin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04996</drugbank-id>
      <name>Satraplatin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Satraplatin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05015</drugbank-id>
      <name>Belinostat</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Belinostat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05022</drugbank-id>
      <name>Amonafide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Amonafide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05076</drugbank-id>
      <name>Fenretinide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fenretinide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05088</drugbank-id>
      <name>Tetrathiomolybdate</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tetrathiomolybdate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05097</drugbank-id>
      <name>Labetuzumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Labetuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05109</drugbank-id>
      <name>Trabectedin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trabectedin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05129</drugbank-id>
      <name>Elsamitrucin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Elsamitrucin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05136</drugbank-id>
      <name>Bavituximab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bavituximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05223</drugbank-id>
      <name>Pracinostat</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pracinostat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05239</drugbank-id>
      <name>Cobimetinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cobimetinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05260</drugbank-id>
      <name>Gallium nitrate</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gallium nitrate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05265</drugbank-id>
      <name>Ecabet</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ecabet.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05294</drugbank-id>
      <name>Vandetanib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vandetanib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05374</drugbank-id>
      <name>Rindopepimut</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rindopepimut.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05424</drugbank-id>
      <name>Canertinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Canertinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05428</drugbank-id>
      <name>Motexafin gadolinium</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Motexafin gadolinium.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05482</drugbank-id>
      <name>7-ethyl-10-hydroxycamptothecin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 7-ethyl-10-hydroxycamptothecin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05524</drugbank-id>
      <name>Pelitinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pelitinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05540</drugbank-id>
      <name>Alanosine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alanosine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05578</drugbank-id>
      <name>Ramucirumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ramucirumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05595</drugbank-id>
      <name>Farletuzumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Farletuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05656</drugbank-id>
      <name>Veltuzumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Veltuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05668</drugbank-id>
      <name>Palifosfamide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Palifosfamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05697</drugbank-id>
      <name>AP 12009</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with AP 12009.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05773</drugbank-id>
      <name>Trastuzumab emtansine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trastuzumab emtansine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05779</drugbank-id>
      <name>Oglufanide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Oglufanide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05786</drugbank-id>
      <name>Irofulven</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Irofulven.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05812</drugbank-id>
      <name>Abiraterone</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Abiraterone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05889</drugbank-id>
      <name>Inotuzumab ozogamicin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Inotuzumab ozogamicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05903</drugbank-id>
      <name>KOS-1584</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with KOS-1584.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05916</drugbank-id>
      <name>CT-011</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with CT-011.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05974</drugbank-id>
      <name>Transcrocetinate</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Transcrocetinate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05996</drugbank-id>
      <name>Glembatumumab vedotin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Glembatumumab vedotin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06013</drugbank-id>
      <name>Aldoxorubicin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Aldoxorubicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06021</drugbank-id>
      <name>AV-412</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with AV-412.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06040</drugbank-id>
      <name>Filanesib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Filanesib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06043</drugbank-id>
      <name>Olaratumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Olaratumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06159</drugbank-id>
      <name>Rubitecan</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rubitecan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06160</drugbank-id>
      <name>Garenoxacin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Garenoxacin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06163</drugbank-id>
      <name>Plevitrexed</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Plevitrexed.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06171</drugbank-id>
      <name>Paclitaxel trevatide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Paclitaxel trevatide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06176</drugbank-id>
      <name>Romidepsin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Romidepsin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06181</drugbank-id>
      <name>IMO-2055</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with IMO-2055.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06186</drugbank-id>
      <name>Ipilimumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ipilimumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06192</drugbank-id>
      <name>Nimotuzumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nimotuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06193</drugbank-id>
      <name>Pixantrone</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pixantrone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06195</drugbank-id>
      <name>Seliciclib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Seliciclib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06199</drugbank-id>
      <name>Atrasentan</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Atrasentan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06233</drugbank-id>
      <name>Ridaforolimus</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ridaforolimus.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06235</drugbank-id>
      <name>Vadimezan</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vadimezan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06246</drugbank-id>
      <name>Exisulind</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Exisulind.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06263</drugbank-id>
      <name>Amrubicin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Amrubicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06266</drugbank-id>
      <name>Lonidamine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lonidamine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06272</drugbank-id>
      <name>Maxacalcitol</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Maxacalcitol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06287</drugbank-id>
      <name>Temsirolimus</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Temsirolimus.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06317</drugbank-id>
      <name>Elotuzumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Elotuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06334</drugbank-id>
      <name>Tucidinostat</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tucidinostat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06365</drugbank-id>
      <name>Sapacitabine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sapacitabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06366</drugbank-id>
      <name>Pertuzumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pertuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06370</drugbank-id>
      <name>Indisulam</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Indisulam.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06420</drugbank-id>
      <name>Annamycin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Annamycin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06423</drugbank-id>
      <name>Endostatin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Endostatin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06433</drugbank-id>
      <name>Tezacitabine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tezacitabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06436</drugbank-id>
      <name>Semaxanib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Semaxanib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06445</drugbank-id>
      <name>Diethylnorspermine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Diethylnorspermine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06461</drugbank-id>
      <name>Squalamine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Squalamine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06478</drugbank-id>
      <name>Porfiromycin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Porfiromycin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06517</drugbank-id>
      <name>MLN576</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with MLN576.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06589</drugbank-id>
      <name>Pazopanib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pazopanib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06595</drugbank-id>
      <name>Midostaurin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Midostaurin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06603</drugbank-id>
      <name>Panobinostat</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Panobinostat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06607</drugbank-id>
      <name>Catumaxomab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Catumaxomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06616</drugbank-id>
      <name>Bosutinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bosutinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06626</drugbank-id>
      <name>Axitinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Axitinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06647</drugbank-id>
      <name>Volociximab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Volociximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06650</drugbank-id>
      <name>Ofatumumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ofatumumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06699</drugbank-id>
      <name>Degarelix</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Degarelix.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06710</drugbank-id>
      <name>Methyltestosterone</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Methyltestosterone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06719</drugbank-id>
      <name>Buserelin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Buserelin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06748</drugbank-id>
      <name>Ginsenoside C</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ginsenoside C.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06769</drugbank-id>
      <name>Bendamustine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bendamustine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06772</drugbank-id>
      <name>Cabazitaxel</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cabazitaxel.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06789</drugbank-id>
      <name>Hydroxyprogesterone caproate</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Hydroxyprogesterone caproate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06791</drugbank-id>
      <name>Lanreotide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lanreotide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06810</drugbank-id>
      <name>Plicamycin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Plicamycin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06813</drugbank-id>
      <name>Pralatrexate</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pralatrexate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06825</drugbank-id>
      <name>Triptorelin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Triptorelin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB07232</drugbank-id>
      <name>Veliparib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Veliparib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB07931</drugbank-id>
      <name>Hexestrol</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Hexestrol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08313</drugbank-id>
      <name>Nocodazole</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nocodazole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08437</drugbank-id>
      <name>Puromycin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Puromycin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08486</drugbank-id>
      <name>Efaproxiral</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Efaproxiral.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08633</drugbank-id>
      <name>TNP-470</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with TNP-470.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08828</drugbank-id>
      <name>Vismodegib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vismodegib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08865</drugbank-id>
      <name>Crizotinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Crizotinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08870</drugbank-id>
      <name>Brentuximab vedotin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Brentuximab vedotin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08871</drugbank-id>
      <name>Eribulin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Eribulin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08875</drugbank-id>
      <name>Cabozantinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cabozantinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08877</drugbank-id>
      <name>Ruxolitinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ruxolitinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08881</drugbank-id>
      <name>Vemurafenib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vemurafenib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08886</drugbank-id>
      <name>Asparaginase Erwinia chrysanthemi</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Asparaginase Erwinia chrysanthemi.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08889</drugbank-id>
      <name>Carfilzomib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Carfilzomib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08896</drugbank-id>
      <name>Regorafenib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Regorafenib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08899</drugbank-id>
      <name>Enzalutamide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Enzalutamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08901</drugbank-id>
      <name>Ponatinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ponatinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08905</drugbank-id>
      <name>Formestane</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Formestane.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08911</drugbank-id>
      <name>Trametinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trametinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08912</drugbank-id>
      <name>Dabrafenib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dabrafenib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08913</drugbank-id>
      <name>Radium Ra 223 dichloride</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Radium Ra 223 dichloride.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08916</drugbank-id>
      <name>Afatinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Afatinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08935</drugbank-id>
      <name>Obinutuzumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Obinutuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08972</drugbank-id>
      <name>Flumequine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Flumequine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09010</drugbank-id>
      <name>Carmofur</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Carmofur.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09031</drugbank-id>
      <name>Miltefosine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Miltefosine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09035</drugbank-id>
      <name>Nivolumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nivolumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09036</drugbank-id>
      <name>Siltuximab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Siltuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09037</drugbank-id>
      <name>Pembrolizumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pembrolizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09052</drugbank-id>
      <name>Blinatumomab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Blinatumomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09053</drugbank-id>
      <name>Ibrutinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ibrutinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09054</drugbank-id>
      <name>Idelalisib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Idelalisib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09063</drugbank-id>
      <name>Ceritinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ceritinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09073</drugbank-id>
      <name>Palbociclib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Palbociclib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09074</drugbank-id>
      <name>Olaparib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Olaparib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09077</drugbank-id>
      <name>Dinutuximab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dinutuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09078</drugbank-id>
      <name>Lenvatinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lenvatinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09079</drugbank-id>
      <name>Nintedanib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nintedanib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09123</drugbank-id>
      <name>Dienogest</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dienogest.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09143</drugbank-id>
      <name>Sonidegib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sonidegib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09239</drugbank-id>
      <name>Niguldipine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Niguldipine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09256</drugbank-id>
      <name>Tegafur</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tegafur.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09274</drugbank-id>
      <name>Artesunate</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Artesunate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09298</drugbank-id>
      <name>Silibinin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Silibinin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09330</drugbank-id>
      <name>Osimertinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Osimertinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09331</drugbank-id>
      <name>Daratumumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Daratumumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09559</drugbank-id>
      <name>Necitumumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Necitumumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09570</drugbank-id>
      <name>Ixazomib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ixazomib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11363</drugbank-id>
      <name>Alectinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alectinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11366</drugbank-id>
      <name>Roquinimex</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Roquinimex.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11526</drugbank-id>
      <name>Masitinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Masitinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11581</drugbank-id>
      <name>Venetoclax</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Venetoclax.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11595</drugbank-id>
      <name>Atezolizumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Atezolizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11616</drugbank-id>
      <name>Pirarubicin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pirarubicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11617</drugbank-id>
      <name>Aclarubicin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Aclarubicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11618</drugbank-id>
      <name>Zorubicin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Zorubicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11630</drugbank-id>
      <name>Temoporfin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Temoporfin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11646</drugbank-id>
      <name>Conatumumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Conatumumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11651</drugbank-id>
      <name>Dactolisib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dactolisib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11662</drugbank-id>
      <name>Rabusertib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rabusertib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11669</drugbank-id>
      <name>Ortataxel</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ortataxel.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11678</drugbank-id>
      <name>Treosulfan</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Treosulfan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11688</drugbank-id>
      <name>2-chloroethyl-3-sarcosinamide-1-nitrosourea</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 2-chloroethyl-3-sarcosinamide-1-nitrosourea.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11694</drugbank-id>
      <name>Ilorasertib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ilorasertib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11714</drugbank-id>
      <name>Durvalumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Durvalumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11716</drugbank-id>
      <name>Misonidazole</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Misonidazole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11717</drugbank-id>
      <name>Epacadostat</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Epacadostat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11718</drugbank-id>
      <name>Encorafenib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Encorafenib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11727</drugbank-id>
      <name>Endostar</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Endostar.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11730</drugbank-id>
      <name>Ribociclib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ribociclib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11737</drugbank-id>
      <name>Icotinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Icotinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11752</drugbank-id>
      <name>Bryostatin 1</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bryostatin 1.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11760</drugbank-id>
      <name>Talazoparib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Talazoparib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11771</drugbank-id>
      <name>Tremelimumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tremelimumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11793</drugbank-id>
      <name>Niraparib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Niraparib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11795</drugbank-id>
      <name>GSK-2636771</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with GSK-2636771.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11800</drugbank-id>
      <name>Tivozanib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tivozanib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11805</drugbank-id>
      <name>Saracatinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Saracatinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11812</drugbank-id>
      <name>Talaporfin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Talaporfin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11828</drugbank-id>
      <name>Neratinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Neratinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11830</drugbank-id>
      <name>Mocetinostat</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mocetinostat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11832</drugbank-id>
      <name>Crenolanib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Crenolanib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11841</drugbank-id>
      <name>Entinostat</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Entinostat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11880</drugbank-id>
      <name>Acridine Carboxamide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Acridine Carboxamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11886</drugbank-id>
      <name>Infigratinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Infigratinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11891</drugbank-id>
      <name>CUDC-907</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with CUDC-907.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11894</drugbank-id>
      <name>Efatutazone</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Efatutazone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11901</drugbank-id>
      <name>Apalutamide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Apalutamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11907</drugbank-id>
      <name>Rociletinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rociletinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11918</drugbank-id>
      <name>Guadecitabine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Guadecitabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11919</drugbank-id>
      <name>6-O-benzylguanine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 6-O-benzylguanine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11945</drugbank-id>
      <name>Avelumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Avelumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11960</drugbank-id>
      <name>Carboxyamidotriazole</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Carboxyamidotriazole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11963</drugbank-id>
      <name>Dacomitinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dacomitinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11967</drugbank-id>
      <name>Binimetinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Binimetinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11972</drugbank-id>
      <name>Rilotumumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rilotumumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11973</drugbank-id>
      <name>Tesevatinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tesevatinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11978</drugbank-id>
      <name>Glasdegib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Glasdegib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11986</drugbank-id>
      <name>Entrectinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Entrectinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11999</drugbank-id>
      <name>Vosaroxin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vosaroxin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12001</drugbank-id>
      <name>Abemaciclib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Abemaciclib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12015</drugbank-id>
      <name>Alpelisib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alpelisib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12025</drugbank-id>
      <name>Triptolide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Triptolide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12028</drugbank-id>
      <name>Broxuridine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Broxuridine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12036</drugbank-id>
      <name>Naquotinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Naquotinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12056</drugbank-id>
      <name>Trebananib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trebananib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12081</drugbank-id>
      <name>Anecortave</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Anecortave.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12082</drugbank-id>
      <name>Vesnarinone</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vesnarinone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12083</drugbank-id>
      <name>Mafosfamide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mafosfamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12085</drugbank-id>
      <name>LCL-161</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with LCL-161.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12089</drugbank-id>
      <name>Lorvotuzumab mertansine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lorvotuzumab mertansine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12108</drugbank-id>
      <name>Taselisib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Taselisib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12124</drugbank-id>
      <name>Namitecan</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Namitecan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12130</drugbank-id>
      <name>Lorlatinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lorlatinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12141</drugbank-id>
      <name>Gilteritinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gilteritinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12142</drugbank-id>
      <name>Duligotuzumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Duligotuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12146</drugbank-id>
      <name>Rigosertib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rigosertib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12147</drugbank-id>
      <name>Erdafitinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Erdafitinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12156</drugbank-id>
      <name>Cordycepin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cordycepin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12174</drugbank-id>
      <name>CUDC-101</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with CUDC-101.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12182</drugbank-id>
      <name>Binetrakin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Binetrakin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12185</drugbank-id>
      <name>Exatecan</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Exatecan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12202</drugbank-id>
      <name>Zalutumumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Zalutumumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12222</drugbank-id>
      <name>Lurtotecan</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lurtotecan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12232</drugbank-id>
      <name>KRN-7000</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with KRN-7000.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12257</drugbank-id>
      <name>Platinum</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Platinum.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12259</drugbank-id>
      <name>CG-200745</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with CG-200745.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12266</drugbank-id>
      <name>Epofolate</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Epofolate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12267</drugbank-id>
      <name>Brigatinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Brigatinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12279</drugbank-id>
      <name>OBP-801</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with OBP-801.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12332</drugbank-id>
      <name>Rucaparib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rucaparib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12340</drugbank-id>
      <name>Navitoclax</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Navitoclax.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12352</drugbank-id>
      <name>Bizelesin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bizelesin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12376</drugbank-id>
      <name>Ricolinostat</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ricolinostat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12379</drugbank-id>
      <name>Indirubin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Indirubin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12381</drugbank-id>
      <name>Merestinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Merestinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12382</drugbank-id>
      <name>R-306465</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with R-306465.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12385</drugbank-id>
      <name>10-hydroxycamptothecin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 10-hydroxycamptothecin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12391</drugbank-id>
      <name>Sagopilone</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sagopilone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12422</drugbank-id>
      <name>Sulforaphane</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sulforaphane.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12459</drugbank-id>
      <name>Belotecan</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Belotecan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12473</drugbank-id>
      <name>Taurolidine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Taurolidine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12483</drugbank-id>
      <name>Copanlisib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Copanlisib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12498</drugbank-id>
      <name>Mogamulizumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mogamulizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12515</drugbank-id>
      <name>9-aminocamptothecin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 9-aminocamptothecin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12525</drugbank-id>
      <name>Molgramostim</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Molgramostim.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12539</drugbank-id>
      <name>Oltipraz</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Oltipraz.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12549</drugbank-id>
      <name>Pyrazoloacridine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pyrazoloacridine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12565</drugbank-id>
      <name>Abexinostat</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Abexinostat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12577</drugbank-id>
      <name>Fosbretabulin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fosbretabulin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12589</drugbank-id>
      <name>Dacetuzumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dacetuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12593</drugbank-id>
      <name>Apaziquone</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Apaziquone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12596</drugbank-id>
      <name>Combretastatin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Combretastatin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12617</drugbank-id>
      <name>Mizoribine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mizoribine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12637</drugbank-id>
      <name>Onapristone</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Onapristone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12638</drugbank-id>
      <name>PU-H71</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with PU-H71.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12645</drugbank-id>
      <name>Givinostat</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Givinostat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12671</drugbank-id>
      <name>Beloranib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Beloranib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12677</drugbank-id>
      <name>Soblidotin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Soblidotin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12681</drugbank-id>
      <name>Salirasib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Salirasib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12688</drugbank-id>
      <name>Moxetumomab Pasudotox</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Moxetumomab Pasudotox.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12692</drugbank-id>
      <name>Gusperimus</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gusperimus.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12695</drugbank-id>
      <name>Phenethyl Isothiocyanate</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Phenethyl Isothiocyanate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12697</drugbank-id>
      <name>Methylselenocysteine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Methylselenocysteine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12701</drugbank-id>
      <name>Intetumumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Intetumumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12730</drugbank-id>
      <name>Dolastatin 10</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dolastatin 10.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12736</drugbank-id>
      <name>Etanidazole</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Etanidazole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12769</drugbank-id>
      <name>Lometrexol</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lometrexol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12797</drugbank-id>
      <name>Ecromeximab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ecromeximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12832</drugbank-id>
      <name>Prednimustine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Prednimustine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12870</drugbank-id>
      <name>Buthionine Sulfoximine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Buthionine Sulfoximine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12873</drugbank-id>
      <name>Dianhydrogalactitol</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dianhydrogalactitol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12881</drugbank-id>
      <name>Indole-3-carbinol</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Indole-3-carbinol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12901</drugbank-id>
      <name>Fiacitabine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fiacitabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12902</drugbank-id>
      <name>Trofosfamide</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trofosfamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12912</drugbank-id>
      <name>Nolatrexed</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nolatrexed.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12916</drugbank-id>
      <name>Mitolactol</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mitolactol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12920</drugbank-id>
      <name>Pinometostat</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pinometostat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12947</drugbank-id>
      <name>Doxifluridine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Doxifluridine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12948</drugbank-id>
      <name>Didox</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Didox.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12967</drugbank-id>
      <name>Mitoguazone</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mitoguazone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12978</drugbank-id>
      <name>Pexidartinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pexidartinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12987</drugbank-id>
      <name>Penclomedine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Penclomedine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12991</drugbank-id>
      <name>Deoxyspergualin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Deoxyspergualin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12996</drugbank-id>
      <name>Acteoside</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Acteoside.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13005</drugbank-id>
      <name>Rebastinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rebastinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13014</drugbank-id>
      <name>Hypericin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Hypericin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13046</drugbank-id>
      <name>Tocladesine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tocladesine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13066</drugbank-id>
      <name>Liarozole</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Liarozole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13069</drugbank-id>
      <name>Nimustine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nimustine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13104</drugbank-id>
      <name>X-396</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with X-396.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13128</drugbank-id>
      <name>Sizofiran</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sizofiran.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13145</drugbank-id>
      <name>Nedaplatin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nedaplatin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13164</drugbank-id>
      <name>Olmutinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Olmutinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13182</drugbank-id>
      <name>Daidzein</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Daidzein.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13243</drugbank-id>
      <name>Tiazofurine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tiazofurine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13304</drugbank-id>
      <name>Triaziquone</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Triaziquone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13318</drugbank-id>
      <name>Demecolcine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Demecolcine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13334</drugbank-id>
      <name>Mannosulfan</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mannosulfan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13339</drugbank-id>
      <name>Etoglucid</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Etoglucid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13375</drugbank-id>
      <name>Edrecolomab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Edrecolomab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13480</drugbank-id>
      <name>Lentinan</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lentinan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13543</drugbank-id>
      <name>Mitobronitol</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mitobronitol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13627</drugbank-id>
      <name>Oxolinic acid</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Oxolinic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13647</drugbank-id>
      <name>Semustine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Semustine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13677</drugbank-id>
      <name>Carboquone</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Carboquone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13767</drugbank-id>
      <name>Vorozole</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vorozole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13809</drugbank-id>
      <name>Paclitaxel poliglumex</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Paclitaxel poliglumex.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13811</drugbank-id>
      <name>Oblimersen</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Oblimersen.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13832</drugbank-id>
      <name>Ranimustine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ranimustine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13874</drugbank-id>
      <name>Enasidenib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Enasidenib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13877</drugbank-id>
      <name>Iniparib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Iniparib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13896</drugbank-id>
      <name>Talimogene laherparepvec</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Talimogene laherparepvec.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13912</drugbank-id>
      <name>Coumermycin A1</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Coumermycin A1.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13916</drugbank-id>
      <name>Toyocamycin</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Toyocamycin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14031</drugbank-id>
      <name>Tretamine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tretamine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14066</drugbank-id>
      <name>Tetrandrine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tetrandrine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14067</drugbank-id>
      <name>Dofequidar</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dofequidar.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14068</drugbank-id>
      <name>Dexniguldipine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dexniguldipine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14568</drugbank-id>
      <name>Ivosidenib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ivosidenib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14644</drugbank-id>
      <name>Methylprednisolone hemisuccinate</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Methylprednisolone hemisuccinate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14646</drugbank-id>
      <name>Prednisone acetate</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Prednisone acetate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14680</drugbank-id>
      <name>Combretastatin A4</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Combretastatin A4.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14707</drugbank-id>
      <name>Cemiplimab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cemiplimab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14723</drugbank-id>
      <name>Larotrectinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Larotrectinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14731</drugbank-id>
      <name>Tagraxofusp</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tagraxofusp.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14765</drugbank-id>
      <name>Rivoceranib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rivoceranib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14792</drugbank-id>
      <name>AZD-5991</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with AZD-5991.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14844</drugbank-id>
      <name>ONC-201</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with ONC-201.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14860</drugbank-id>
      <name>Ensartinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ensartinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14865</drugbank-id>
      <name>Human interleukin-2</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Human interleukin-2.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14877</drugbank-id>
      <name>Lintuzumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lintuzumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14947</drugbank-id>
      <name>Bermekimab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bermekimab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14951</drugbank-id>
      <name>Etirinotecan pegol</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Etirinotecan pegol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15035</drugbank-id>
      <name>Zanubrutinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Zanubrutinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15057</drugbank-id>
      <name>NUC-1031</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with NUC-1031.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15157</drugbank-id>
      <name>Voruciclib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Voruciclib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15215</drugbank-id>
      <name>KRN-5500</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with KRN-5500.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15289</drugbank-id>
      <name>Perillyl alcohol</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Perillyl alcohol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15321</drugbank-id>
      <name>Tefinostat</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tefinostat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15334</drugbank-id>
      <name>Biochanin A</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Biochanin A.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15351</drugbank-id>
      <name>Dihematoporphyrin ether</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dihematoporphyrin ether.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15366</drugbank-id>
      <name>SOR-C13</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with SOR-C13.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15383</drugbank-id>
      <name>Pidilizumab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pidilizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15419</drugbank-id>
      <name>Nanatinostat</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nanatinostat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15466</drugbank-id>
      <name>Tallimustine</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tallimustine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12062</drugbank-id>
      <name>Volasertib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Volasertib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14811</drugbank-id>
      <name>Isatuximab</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Isatuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15102</drugbank-id>
      <name>Pemigatinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pemigatinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11791</drugbank-id>
      <name>Capmatinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Capmatinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15685</drugbank-id>
      <name>Selpercatinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Selpercatinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15699</drugbank-id>
      <name>Brexucabtagene autoleucel</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Brexucabtagene autoleucel.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15822</drugbank-id>
      <name>Pralsetinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pralsetinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11942</drugbank-id>
      <name>Selinexor</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Selinexor.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12500</drugbank-id>
      <name>Fedratinib</name>
      <description>The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fedratinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00531</drugbank-id>
      <name>Cyclophosphamide</name>
      <description>The risk or severity of pulmonary toxicity can be increased when Erythropoietin is combined with Cyclophosphamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00984</drugbank-id>
      <name>Nandrolone phenpropionate</name>
      <description>The therapeutic efficacy of Erythropoietin can be increased when used in combination with Nandrolone phenpropionate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08804</drugbank-id>
      <name>Nandrolone decanoate</name>
      <description>The therapeutic efficacy of Erythropoietin can be increased when used in combination with Nandrolone decanoate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13169</drugbank-id>
      <name>Nandrolone</name>
      <description>The therapeutic efficacy of Erythropoietin can be increased when used in combination with Nandrolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00178</drugbank-id>
      <name>Ramipril</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Ramipril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00492</drugbank-id>
      <name>Fosinopril</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Fosinopril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00519</drugbank-id>
      <name>Trandolapril</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Trandolapril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00542</drugbank-id>
      <name>Benazepril</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Benazepril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00584</drugbank-id>
      <name>Enalapril</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Enalapril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00691</drugbank-id>
      <name>Moexipril</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Moexipril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00722</drugbank-id>
      <name>Lisinopril</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Lisinopril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00790</drugbank-id>
      <name>Perindopril</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Perindopril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00881</drugbank-id>
      <name>Quinapril</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Quinapril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00886</drugbank-id>
      <name>Omapatrilat</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Omapatrilat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01180</drugbank-id>
      <name>Rescinnamine</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Rescinnamine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01197</drugbank-id>
      <name>Captopril</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Captopril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01340</drugbank-id>
      <name>Cilazapril</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Cilazapril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01348</drugbank-id>
      <name>Spirapril</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Spirapril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08836</drugbank-id>
      <name>Temocapril</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Temocapril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09477</drugbank-id>
      <name>Enalaprilat</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Enalaprilat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11783</drugbank-id>
      <name>Imidapril</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Imidapril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13166</drugbank-id>
      <name>Zofenopril</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Zofenopril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13312</drugbank-id>
      <name>Delapril</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Delapril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14125</drugbank-id>
      <name>Benazeprilat</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Benazeprilat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14207</drugbank-id>
      <name>Fosinoprilat</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Fosinoprilat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14208</drugbank-id>
      <name>Ramiprilat</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Ramiprilat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14209</drugbank-id>
      <name>Trandolaprilat</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Trandolaprilat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14210</drugbank-id>
      <name>Moexiprilat</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Moexiprilat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14213</drugbank-id>
      <name>Perindoprilat</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Perindoprilat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14217</drugbank-id>
      <name>Quinaprilat</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Quinaprilat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14231</drugbank-id>
      <name>Quinoline Yellow WS</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Quinoline Yellow WS.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15565</drugbank-id>
      <name>Cilazaprilat</name>
      <description>The serum concentration of Erythropoietin can be decreased when it is combined with Cilazaprilat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00309</drugbank-id>
      <name>Vindesine</name>
      <description>The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vindesine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00361</drugbank-id>
      <name>Vinorelbine</name>
      <description>The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vinorelbine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00541</drugbank-id>
      <name>Vincristine</name>
      <description>The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vincristine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00570</drugbank-id>
      <name>Vinblastine</name>
      <description>The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vinblastine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05168</drugbank-id>
      <name>Vintafolide</name>
      <description>The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vintafolide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11641</drugbank-id>
      <name>Vinflunine</name>
      <description>The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vinflunine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13374</drugbank-id>
      <name>Vincamine</name>
      <description>The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vincamine.</description>
    </drug-interaction>
  </drug-interactions>
  <sequences>
    <sequence format="FASTA">&gt;DB00016 (Erythropoietin) sequence
APPRLICDSRVLERYLLEAKEAENITTGCAEHCSLNENITVPDTKVNFYAWKRMEVGQQA
VEVWQGLALLSEAVLRGQALLVNSSQPWEPLQLHVDKAVSGLRSLTTLLRALGAQKEAIS
PPDAASAAPLRTITADTFRKLFRVYSNFLRGKLKLYTGEACRTGDR</sequence>
  </sequences>
  <experimental-properties>
    <property>
      <kind>Melting Point</kind>
      <value>53 °C</value>
      <source>Arakawa, T. et al., Biosci. Biotechnol. Biochem. 65:1321-1327 (2001)</source>
    </property>
    <property>
      <kind>Isoelectric Point</kind>
      <value>8.75</value>
      <source/>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>18396.1</value>
      <source/>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C815H1317N233O241S5</value>
      <source/>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>299</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46508122</identifier>
    </external-identifier>
    <external-identifier>
      <resource>GenBank</resource>
      <identifier>X02158</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PharmGKB</resource>
      <identifier>PA10072</identifier>
    </external-identifier>
    <external-identifier>
      <resource>UniProtKB</resource>
      <identifier>P01588</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Therapeutic Targets Database</resource>
      <identifier>DAP000202</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Epoetin_alfa</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL1201565</identifier>
    </external-identifier>
    <external-identifier>
      <resource>RxCUI</resource>
      <identifier>105694</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links>
    <external-link>
      <resource>RxList</resource>
      <url>http://www.rxlist.com/cgi/generic/epoetin.htm</url>
    </external-link>
    <external-link>
      <resource>Drugs.com</resource>
      <url>http://www.drugs.com/cdi/epoetin-alfa.html</url>
    </external-link>
  </external-links>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target>
      <id>BE0000654</id>
      <name>Erythropoietin receptor</name>
      <organism>Humans</organism>
      <actions>
        <action>agonist</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A1764</ref-id>
            <pubmed-id>16505108</pubmed-id>
            <citation>LaMontagne KR, Butler J, Marshall DJ, Tullai J, Gechtman Z, Hall C, Meshaw A, Farrell FX: Recombinant epoetins do not stimulate tumor growth in erythropoietin receptor-positive breast carcinoma models. Mol Cancer Ther. 2006 Feb;5(2):347-55.</citation>
          </article>
          <article>
            <ref-id>A1766</ref-id>
            <pubmed-id>17575216</pubmed-id>
            <citation>Kokhaei P, Abdalla AO, Hansson L, Mikaelsson E, Kubbies M, Haselbeck A, Jernberg-Wiklund H, Mellstedt H, Osterborg A: Expression of erythropoietin receptor and in vitro functional effects of epoetins in B-cell malignancies. Clin Cancer Res. 2007 Jun 15;13(12):3536-44.</citation>
          </article>
          <article>
            <ref-id>A9</ref-id>
            <pubmed-id>11752352</pubmed-id>
            <citation>Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="P19235" source="Swiss-Prot">
        <name>Erythropoietin receptor</name>
        <general-function>Identical protein binding</general-function>
        <specific-function>Receptor for erythropoietin. Mediates erythropoietin-induced erythroblast proliferation and differentiation. Upon EPO stimulation, EPOR dimerizes triggering the JAK2/STAT5 signaling cascade. In some cell types, can also activate STAT1 and STAT3. May also activate the LYN tyrosine kinase.Isoform EPOR-T acts as a dominant-negative receptor of EPOR-mediated signaling.</specific-function>
        <gene-name>EPOR</gene-name>
        <locus>19p13.3-p13.2</locus>
        <cellular-location>Cell membrane</cellular-location>
        <transmembrane-regions>251-273</transmembrane-regions>
        <signal-regions>1-24</signal-regions>
        <theoretical-pi>4.37</theoretical-pi>
        <molecular-weight>55064.725</molecular-weight>
        <chromosome-location>19</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:3416</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>EPOR</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>M60459</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>182245</identifier>
          </external-identifier>
          <external-identifier>
            <resource>Guide to Pharmacology</resource>
            <identifier>1718</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P19235</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>EPOR_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>EPO-R</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001304|Erythropoietin receptor
MDHLGASLWPQVGSLCLLLAGAAWAPPPNLPDPKFESKAALLAARGPEELLCFTERLEDL
VCFWEEAASAGVGPGNYSFSYQLEDEPWKLCRLHQAPTARGAVRFWCSLPTADTSSFVPL
ELRVTAASGAPRYHRVIHINEVVLLDAPVGLVARLADESGHVVLRWLPPPETPMTSHIRY
EVDVSAGNGAGSVQRVEILEGRTECVLSNLRGRTRYTFAVRARMAEPSFGGFWSAWSEPV
SLLTPSDLDPLILTLSLILVVILVLLTVLALLSHRRALKQKIWPGIPSPESEFEGLFTTH
KGNFQLWLYQNDGCLWWSPCTPFTEDPPASLEVLSERCWGTMQAVEPGTDDEGPLLEPVG
SEHAQDTYLVLDKWLLPRNPPSEDLPGPGGSVDIVAMDEGSEASSCSSALASKPSPEGAS
AASFEYTILDPSSQLLRPWTLCPELPPTPPHLKYLYLVVSDSGISTDYSSGDSQGAQGGL
SDGPYSNPYENSLIPAAEPLPPSYVACS</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0010455|Erythropoietin receptor (EPOR)
ATGGACCACCTCGGGGCGTCCCTCTGGCCCCAGGTCGGCTCCCTTTGTCTCCTGCTCGCT
GGGGCCGCCTGGGCGCCCCCGCCTAACCTCCCGGACCCCAAGTTCGAGAGCAAAGCGGCC
TTGCTGGCGGCCCGGGGGCCCGAAGAGCTTCTGTGCTTCACCGAGCGGTTGGAGGACTTG
GTGTGTTTCTGGGAGGAAGCGGCGAGCGCTGGGGTGGGCCCGGGCAACTACAGCTTCTCC
TACCAGCTCGAGGATGAGCCATGGAAGCTGTGTCGCCTGCACCAGGCTCCCACGGCTCGT
GGTGCGGTGCGCTTCTGGTGTTCGCTGCCTACAGCCGACACGTCGAGCTTCGTGCCCCTA
GAGTTGCGCGTCACAGCAGCCTCCGGCGCTCCGCGATATCACCGTGTCATCCACATCAAT
GAAGTAGTGCTCCTAGACGCCCCCGTGGGGCTGGTGGCGCGGTTGGCTGACGAGAGCGGC
CACGTAGTGTTGCGCTGGCTCCCGCCGCCTGAGACACCCATGACGTCTCACATCCGCTAC
GAGGTGGACGTCTCGGCCGGCAACGGCGCAGGGAGCGTACAGAGGGTGGAGATCCTGGAG
GGCCGCACCGAGTGTGTGCTGAGCAACCTGCGGGGCCGGACGCGCTACACCTTCGCCGTC
CGCGCGCGTATGGCTGAGCCGAGCTTCGGCGGCTTCTGGAGCGCCTGGTCGGAGCCTGTG
TCGCTGCTGACGCCTAGCGACCTGGACCCCCTCATCCTGACGCTCTCCCTCATCCTCGTG
GTCATCCTGGTGCTGCTGACCGTGCTCGCGCTGCTCTCCCACCGCCGGGCTCTGAAGCAG
AAGATCTGGCCTGGCATCCCGAGCCCAGAGAGCGAGTTTGAAGGCCTCTTCACCACCCAC
AAGGGTAACTTCCAGCTGTGGCTGTACCAGAATGATGGCTGCCTGTGGTGGAGCCCCTGC
ACCCCCTTCACGGAGGACCCACCTGCTTCCCTGGAAGTCCTCTCAGAGCGCTGCTGGGGG
ACGATGCAGGCAGTGGAGCCGGGGACAGATGATGAGGGCCCCCTGCTGGAGCCAGTGGGC
AGTGAGCATGCCCAGGATACCTATCTGGTGCTGGACAAATGGTTGCTGCCCCGGAACCCG
CCCAGTGAGGACCTCCCAGGGCCTGGTGGCAGTGTGGACATAGTGGCCATGGATGAAGGC
TCAGAAGCATCCTCCTGCTCATCTGCTTTGGCCTCGAAGCCCAGCCCAGAGGGAGCCTCT
GCTGCCAGCTTTGAGTACACTATCCTGGACCCCAGCTCCCAGCTCTTGCGTCCATGGACA
CTGTGCCCTGAGCTGCCCCCTACCCCACCCCACCTAAAGTACCTGTACCTTGTGGTATCT
GACTCTGGCATCTCAACTGACTACAGCTCAGGGGACTCCCAGGGAGCCCAAGGGGGCTTA
TCCGATGGCCCCTACTCCAACCCTTATGAGAACAGCCTTATCCCAGCCGCTGAGCCTCTG
CCCCCCAGCTATGTGGCTTGCTCTTAG</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00041</identifier>
            <name>fn3</name>
          </pfam>
          <pfam>
            <identifier>PF09067</identifier>
            <name>EpoR_lig-bind</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular region</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>integral component of plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>erythropoietin receptor activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>identical protein binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>brain development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>decidualization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>erythropoietin-mediated signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>heart development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of neuron apoptotic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of cytosolic calcium ion concentration</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>signal transduction</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>